Browsing by Author "Ascaso Gimilio, Juan Francisco"

Sort by: Order: Results:

  • Millán Núñez-Cortés, Jesús; Cases Amenós, Aleix; Ascaso Gimilio, Juan Francisco; Barrios Alonso, Vivencio; Pascual Fuster, Vicente; Pedro-Botet, Juan Carlos; Pintó Sala, Xavier; Serrano Cumplido, Adalberto (SpringerOpen, 2017)
    INTRODUCTION AND OBJECTIVES: Despite the recognized clinical benefit of statins on cardiovascular prevention, providing correct management of hypercholesterolaemia, possible adverse effects of their use cannot be disregarded. ...
  • Pedro-Botet, Juan Carlos; Ascaso Gimilio, Juan Francisco; Barrios Alonso, Vivencio; Sierra, Alejandro de la; Escalada, Javier; Millán Núñez-Cortés, Jesús; Mostaza, José María; Pérez-Martínez, Pablo; Pintó Sala, Xavier; Salas-Salvadó, Jordi; Valdivielso, Pedro (Dove Medical Pres, 2018)
    Metabolic syndrome (MetS), a disorder with a high and growing prevalence, is a recognized risk factor for cardiovascular disease (CVD) and type 2 diabetes. It is a constellation of clinical and metabolic risk factors that ...
  • Cases Amenós, Aleix; Pedro-Botet, Juan Carlos; Pascual Fuster, Vicente; Barrios Alonso, Vivencio; Pintó Sala, Xavier; Ascaso Gimilio, Juan Francisco; Nuñez-Cortes, Jesús Millan; Serrano Cumplido, Adalberto (Sociedad Española de Nefrologia, 2016)
    Antecedentes y objetivos: Este estudio post hoc analizó la percepción de la importancia de la enfermedad renal crónica (ERC) en el cribado de la dislipidemia y en la elección del tratamiento con estatinas entre médicos de ...
  • Climent Biescas, Elisenda; Pérez-Calahorra, Sofía; Marco-Benedí, Victoria; Plana, Nuria; Sánchez, Rosa; Ros, Emilio; Ascaso Gimilio, Juan Francisco; Puzo, Jose; Almagro, Fátima; Lahoz, Carlos; Civeira, F.; Pedro-Botet, Juan Carlos (Nature Publishing Group, 2017)
    Patients with heterozygous familial hypercholesterolemia (HeFH) have been reported to be less vulnerable to type 2 diabetes mellitus (T2DM), although the mechanism is unknown. The aims of the present study were to assess ...